Adds xylazine to the depressants designated as controlled substances with the exception of use in cattle or other nonhuman species if approved by the.
New York Assembly Bill A05099 amends the public health law to classify xylazine as a controlled substance, with an exception for its use in cattle or other nonhuman species if approved by the federal food and drug administration. This bill targets individuals who knowingly and willfully administer, prescribe, dispense, or distribute xylazine for human consumption or other purposes not approved by the FDA. Violations will incur penalties similar to those for other controlled substance offenses. The bill is set to take effect 30 days after becoming law.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.